GB201912411D0 - Crystalline forms of ivosidenib - Google Patents
Crystalline forms of ivosidenibInfo
- Publication number
- GB201912411D0 GB201912411D0 GBGB1912411.4A GB201912411A GB201912411D0 GB 201912411 D0 GB201912411 D0 GB 201912411D0 GB 201912411 A GB201912411 A GB 201912411A GB 201912411 D0 GB201912411 D0 GB 201912411D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- ivosidenib
- crystalline forms
- crystalline
- forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- WIJZXSAJMHAVGX-DHLKQENFSA-N ivosidenib Chemical compound FC1=CN=CC(N([C@H](C(=O)NC2CC(F)(F)C2)C=2C(=CC=CC=2)Cl)C(=O)[C@H]2N(C(=O)CC2)C=2N=CC=C(C=2)C#N)=C1 WIJZXSAJMHAVGX-DHLKQENFSA-N 0.000 title 1
- 229950010738 ivosidenib Drugs 0.000 title 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1912411.4A GB201912411D0 (en) | 2019-08-29 | 2019-08-29 | Crystalline forms of ivosidenib |
| PCT/GB2020/052016 WO2021038204A1 (en) | 2019-08-29 | 2020-08-21 | Crystalline forms of ivosidenib |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1912411.4A GB201912411D0 (en) | 2019-08-29 | 2019-08-29 | Crystalline forms of ivosidenib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201912411D0 true GB201912411D0 (en) | 2019-10-16 |
Family
ID=68207040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1912411.4A Ceased GB201912411D0 (en) | 2019-08-29 | 2019-08-29 | Crystalline forms of ivosidenib |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201912411D0 (en) |
| WO (1) | WO2021038204A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019104318A1 (en) * | 2017-11-27 | 2019-05-31 | Teva Pharmaceuticals Usa, Inc. | Solid state forms of ivosidenib |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015229214B2 (en) * | 2014-03-14 | 2019-07-11 | Les Laboratoires Servier | Pharmaceutical compositions of therapeutically active compounds |
| MA43000B1 (en) * | 2015-10-15 | 2021-11-30 | Celgene Corp | Combination therapy for the treatment of malignant tumors |
| WO2019104318A1 (en) * | 2017-11-27 | 2019-05-31 | Teva Pharmaceuticals Usa, Inc. | Solid state forms of ivosidenib |
| EA202190217A1 (en) * | 2018-07-06 | 2021-04-16 | Аджиос Фармасьютикалз, Инк. | FORMS OF IVOSIDENIB AND PHARMACEUTICAL COMPOSITIONS |
-
2019
- 2019-08-29 GB GBGB1912411.4A patent/GB201912411D0/en not_active Ceased
-
2020
- 2020-08-21 WO PCT/GB2020/052016 patent/WO2021038204A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021038204A1 (en) | 2021-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276644A (en) | Novel crystalline forms | |
| IL286218A (en) | Solid state forms of ripretinib | |
| SG10202111695RA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SI3577125T1 (en) | Crystalline forms of tenofovir alafenamide | |
| EP3250562A4 (en) | Crystalline forms of c21h22ci2n4o2 | |
| EP3684358A4 (en) | New crystalline polymorph of ponesimod | |
| PL3532457T3 (en) | Crystalline forms of hydroxynorketamine | |
| ZA201906464B (en) | Crystalline forms of (s)-afoxolaner | |
| IL269073A (en) | Crystalline forms of obeticholic acid | |
| SI3529236T1 (en) | Crystalline forms of eravacycline | |
| IL270961A (en) | Crystalline form of n-butyldeoxygalactonojirimycin | |
| EP3247399A4 (en) | Crystalline forms of efinaconazole | |
| IL285219A (en) | Crystal of diarylthiohydantoin compound | |
| SG11202108905UA (en) | Crystalline form of an avibactam derivative | |
| IL276107A (en) | Solid forms of fasoracetam | |
| GB201912411D0 (en) | Crystalline forms of ivosidenib | |
| SG11202105355XA (en) | Crystalline salts of corydalmine | |
| GB201915908D0 (en) | Crystalline forms of entrectinib | |
| GB201910665D0 (en) | Novel form of compounds | |
| EP3687987A4 (en) | Crystalline forms of lenalidomide | |
| GB201911797D0 (en) | Crystalline forms | |
| IL270937A (en) | Crystalline forms of seletalisib | |
| GB202009218D0 (en) | Crystalline forms of entrectinib | |
| HK40087944A (en) | Crystalline forms of tenofovira lafenamide | |
| IL276108A (en) | Fasoracetam crystalline forms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |